Virtus Biotech Clinical Trials ETF BBC
43.02 USD +2.29 (+5.62%)
At closeNov 6, 2026, 4:00 PM EST
43.02 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
41.03 Day range 43.28
29.69 52-week range 56.03
- YTD
- +11.57%
- 1 year
- +43.26%
- Market cap
- 32.59M
- YTD return
- +11.57%
- 1-year return
- +43.26%
- Volume
- 97.14K
- Avg volume
- 29.35K
- Open
- 41.01
- Previous close
- 40.73
- Day's range
- 41.03 – 43.28
- 52-week range
- 29.69 – 56.03
5D -0.29 (-0.67%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 27.91
- 200-day average
- 27.48
About Virtus Biotech Clinical Trials ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
News
Your note
Sign in to keep a note on BBC — it syncs with the Stock Master app.